HNO International Reports Revenue Decline and Net Loss Reduction for Six Months Ended April 30, 2026

HNO International, Inc. reported its financial results for the three and six months ended April 30, 2026, revealing a revenue of $33,821 for both periods, a decrease from $43,708 in the same periods of 2025. The company attributed this revenue to its role in facilitating the delivery of hydrogen equipment, acting as an agent without taking control of the goods. Consequently, the gross profit mirrored the revenue figures, as no cost of goods sold was recorded. The net loss for the three months was $400,825, a reduction from a loss of $470,066 in the prior year, while the six-month net loss was $582,894, significantly lower than the $5,931,459 loss reported in the same period of 2025.

The company’s operating expenses for the three months ended April 30, 2026, totaled $285,223, down from $386,672 in the previous year, primarily due to reduced general and administrative costs, which fell to $165,081 from $314,323. The decrease in expenses was attributed to lower professional fees and a decline in administrative overhead. For the six-month period, general and administrative expenses also decreased significantly to $286,570 from $5,708,985, largely due to the absence of stock-based compensation, which had accounted for a substantial portion of the previous year's expenses.

HNO International's balance sheet as of April 30, 2026, showed total assets of $1,388,535, down from $1,731,020 at the end of the previous fiscal year. Current liabilities remained relatively stable at $2,759,638, compared to $2,765,768 in the prior period. The company reported a stockholders' deficit of $1,961,103, an increase from $1,629,950, reflecting ongoing financial challenges. The company’s cash position improved to $145,670 from $9,525, indicating a positive cash flow trend, although the working capital deficit widened to $2,613,968 from $2,422,574.

Strategically, HNO International has been active in securing financing to support its operations. The company entered into an Equity Purchase Agreement with Lambda Ventures LLC, allowing it to sell up to $30 million of common stock over 24 months. Additionally, the company has engaged in convertible note financings, including recent transactions in April and May 2026, to bolster its capital resources. However, the company acknowledged substantial doubt about its ability to continue as a going concern, emphasizing the need for additional funding to sustain operations and meet obligations.

Looking ahead, HNO International is focused on navigating market conditions and potential increases in labor and material costs. The management is actively seeking additional capital through equity financing and exploring strategic partnerships to enhance its financial stability. The company remains committed to its mission of developing green hydrogen technologies, which are increasingly relevant in the context of global decarbonization efforts. However, the success of these initiatives will depend on the company's ability to secure necessary funding and manage operational costs effectively.